GS1 rolls up sleeves on pedigree; Help wanted in Iceland;

> Work is scheduled to begin this week by the GS1 EPCglobal Discovery Services Work Group to convert collected drug pedigree business and technical requirements into a standard. Blog

> Generics maker Actavis Group will expand its manufacturing site in Iceland, yielding a 50% capacity increase and 50 new jobs. Article

> BASF will add spray drying of APIs and formulations to its offerings, thanks to a deal with GEA Niro. Release

> Tianjin Tasly Sants Pharmaceuticals in China has deployed SAP's ERP Central Component (ECC) solution with help from HCL Axon. Item

> NeoStem's China subsidiary, Suzhou Erye Pharma, has gotten the nod from Chinese regulators to manufacture two penicillin products at a new facility. Article

> SynCo Bio Partners will provide both process validation and GMP manufacturing services to support the commercial launch of two products for an unnamed biopharma company. Item

> SCM Pharma, a U.K. manufacturer of clinical-trial and commercial-market drugs, has won a $47,000 export grant from the government to build its international business. Article

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.